Results 241 to 250 of about 115,857 (253)

JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment

Therapeutic Advances in Hematology, 2011
Alessandro Maria Vannucchi, Paola Guglielmelli, Lisa Pieri   +2 more
exaly  

JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms

Molecular and Cellular Endocrinology, 2017
Claire N Harrison
exaly  

Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy

Expert Review of Hematology, 2018
Martin Griesshammer, Kai Wille, Parvis Sadjadian   +2 more
exaly  

Mutations in myeloproliferative neoplasms – their significance and clinical use

Expert Review of Hematology, 2017
Robert Kralovics, Fiorella Schischlik
exaly  

Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation

Leukemia and Lymphoma, 2014
Fabio P S Santos, Raphael E Pollock, Srdan Verstovsek   +2 more
exaly  

Janus kinase inhibitors for the treatment of myeloproliferative neoplasms

Expert Opinion on Pharmacotherapy, 2014
Ruben Mesa, Allison C Rosenthal
exaly  

Myeloproliferative Neoplasms

2020
Hans Michael Kvasnicka, Attilio Orazi
openaire   +1 more source

Mechanisms of mutations in myeloproliferative neoplasms

Best Practice and Research in Clinical Haematology, 2009
Ross L Levine
exaly  

Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Seminars in Hematology, 2018
João F Lacerda
exaly  

Myeloproliferative Neoplasms

2014
Farah Shariff, Claire Harrison
openaire   +2 more sources